bioavailability of glp-1 treatments medications safe to continue before surgery in patients with diabetes and obesity GLP-1R Agonists for Weight Loss

Is switching your permanent day a right choice

Characterizing the retinal phenotype of the Thy1-h[A30P]-syn mouse model of Parkinson's disease

Oxidative stress in nonalcoholic fatty liver disease: Pathogenesis and antioxidant therapies

Graphene hydrogel nanoparticles are outstanding drug delivery systems, owing to their unique properties that combine the characteristics of high water content with a very small (nano) size

The authors believe that additional research and substantial efforts are needed to standardize the terminology of benign (and malignant) melanocytic neoplasms

FDA Disclaimer: These statements have not been evaluated by the United States Food and Drug Administration